Immunogenic properties of renal cell carcinoma and the pathogenesis of osteolytic bone metastases

International Journal of Oncology

Volumn 34, Issue 5, 2009, Pages 1387-1393

  Perut, Francesca ^a   Cenni, Elisabetta ^a   Unger, Ronald E ^c   Kirkpatrick, C James ^c   Giunti, Armando ^a,b   Baldini, Nicola ^a,b  

^a Laboratory for Pathophysiology of Orthopaedic Implants   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Adhesion molecules; Endothelial cells; Inflammation; Osteoclast; Renal carcinoma

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; KIDNEY CARCINOMA; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; UMBILICAL VEIN;

BONE NEOPLASMS; CARCINOMA, RENAL CELL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; E-SELECTIN; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY NEOPLASMS; MODELS, BIOLOGICAL; OSTEOLYSIS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 67649442532     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000266     Document Type: Article

References (31)

1. Thurnher M, Radmayr C, Hobisch A, Bock G, Romani N, Bartsch G and Klocher H: Tumor-infiltrating T lymphocytes from renal-cell carcinoma express B7-1 (CD80): T-cell expansion by T-T cell co-stimulation. Int J Cancer 62: 559-564, 1995.
2. Holtl L, Zelle-Rieser C, Gander, Papesh C, Ramoner R, Bartsch G, Rogatsch H, Barsoum AL, Coggin JH Jr and Thurnher M: Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Clin Cancer Res 8: 3369-3376, 2002.
3. Fukata S, Inoue K, Kamada M, Kawada C, Furihata M, Ohtsuki Y and Shuin T: Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma. Cancer 103: 931-942, 2005.
4. Aoki J, Yamamoto I, Hino M, Shigeno C, Kitamura N, Sone T, Shiomi K and Konishi J: Osteoclast-mediated osteolysis in bone metastasis from renal cell carcinoma. Cancer 62: 98-104, 1988.
5. Unger RE, Krump-Konvalinkova V, Peters K and Kirkpatrick CJ: In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res 64: 384-397, 2002.
6. Steinbach F, Tanabe K, Alexander J, Edinger M, Tubbs R, Brenner W, Stockle M, Novick AC and Klein EA: The influence of cytokines on the adhesion of renal cancer cells to endothelium. J Urol 155: 743-748, 1966.
7. Dimitroff CJ, Lechpammer M, Long-Woodward D and Kutok JL: Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 64: 5261-5269, 2004.
8. Tei K, Kawakami-Kimura N, Taguchi O, Kumamoto K, Higashiyama S, Taniguchi N, Toda K, Kawata R, Hisa Y and Kannagi R: Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res 62: 6289-6296, 2002.
9. Yasuda M, Shimizu S, Ohhinata K, Naito S, Tokuyama S, Mori Y, Kiuchi Y and Yamamoto T: Differential roles of ICAM-1 and E-selectin in polymorphonuclear leukocyte-induced angiogenesis. Am J Physiol Cell Physiol 282: C917-C925, 2002.
10. McGowan NW, Walker EJ, Macpherson H, Ralston SH and Helfrich MH: Cytokine-activated endothelium recruits osteoclast precursors. Endocrinology 142: 1678-1681, 2001.
11. + monocytes that develop with RANKL into functional osteoclasts. J Bone Miner Res 21: 193-206, 2006.
12. Lavigne P, Benderdour M, Shi Q, LajeunesseD and Fernandes JC: Involvement of ICAM-1 in bone metabolism: a potential target in the treatment of bone diseases? Expert Opin Biol Ther 5: 313-320, 2005.
13. Roodman GD: Cell biology of the osteoclast. Exp Hematol 27: 1229-1241, 1999.
14. Harada H, Kukita T, Kukita A, Iwamoto Y and Iijima T: Involvement of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 in osteoclastogenesis: a possible role in direct interaction between osteoclast precursors. Endocrinology 139: 3967-3975, 1988.
15. Akatsu T, Ono K, Murakami T, Katayama Y, Nishikawa M, Wada S, Yamamoto M, Kugai N, Matsuura N, Takada Y and Nagata N: Chinese hamster ovary cells expressing alpha4beta1 integrin stimulate osteoclast formation in vitro. J Bone Miner Res 13: 1251-1259, 1988.
16. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
17. Jaffe EA, Nachman RL, Becker CG and Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756, 1973.
18. Avnet S, Cenni E, Granchi D, Perut F, Amato I, Battistelli L, Brandi ML, Giunti A and Baldini N: Isolation and characterization of a new cell line from a renal carcinoma bone metastasis. Anticancer Res 24: 1705-1711, 2004.
19. Bjornland K, Flatmark K, Pettersen S, Aaasen AO, Fodstad O and Maelandsmo GM: Matrix metalloproteinases participate in osteosarcoma invasion. J Surg Res 127: 151-156, 2005.
20. Mulders P, Figlin R, deKernion JB, Wiltrout R, Linehan M, Parkinson D, deWolf W and Belldegrun A: Renal cell carcinoma: recent progress and future directions. Cancer Res 57: 5189-5195, 1997.
21. Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM and Moskovtchenko JF: Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 52: 3317-3322, 1992.
22. Negrier S, Perol D, Menetrier-Caux C, Escudier B, Pallardy M, Ravaud A, Douillard JY, Chevreau C, Lasset C and Blay JY: Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6 - from the Groupe Francais d'Immunotherapie. J Clin Oncol 22: 2371-2378, 2004.
23. Muller WA: Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24: 327-334, 2003.
24. Watson C, Whittaker S, Smith N, Vora AJ, Dumonde DC and Brown KA: IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol 105: 112-119, 1996.
25. Tanabe K, Campbell SC, Alexander J, Steinbach F, Edinger MG, Tubbs RR, Novick AC and Klein EA: Molecular regulation of intercellular adhesion molecule 1 (ICAM-1) expression in renal cell carcinoma. Urol Res 25: 231-238, 1997.
26. Mathieu S, Prorok M, Benoliel AM, Uch R, Langlet C, Bongrand P, Gerolami R and El-Battari A: Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin. Am J Pathol 164: 371-383, 2004.
27. Tozawa K, Okamoto T, Kawai N, Hashimoto Y, Hayashi Y and Kohri K: Positive correlation between sialyl Lewis X expression and pathologic findings in renal cell carcinoma. Kidney Int 67: 1391-1396, 2005.
28. Colucci S, Mori G, Vaira S, Brunetti G, Greco G, Mancini L, Simone GM, Sardelli F, Koverech A, Zallone A and Grano M: L-carnitine and isovaleryl L-carnitine fumarate positively affect human osteoblast proliferation and differentiation in vitro. Calcif Tissue Int 76: 458-465, 2005.
29. Humphrey EL, Williams JH, Davie MW and Marshall MJ: Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone 38: 652-661, 2005.
30. Matsuo K and Irie N: Osteoclast-osteoblast communication. Arch Biochem Biophys 473: 201-209, 2008.
31. Konig B, Steinbach F, Janocha B, Drynda A, Stumm M, Philipp C, Allhoff EP and Konig W: The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma. Anticancer Res 19: 1519-1524, 1999.